首页|论基于基因组学的中药材定向培育策略与展望

论基于基因组学的中药材定向培育策略与展望

扫码查看
为推动和加快中药材品种培育和种业发展,亟需加强中药材种质创新的研究和实践,建立具有中药特色的种质创新途径.育种核心种质的选择与合理组配是决定育种成效的关键,合理利用外来品种、地方品种或野生近缘种进行种质扩增、改良与创新,在中药材品种培育中发挥重要作用.基因组学技术的发展推动了中药材种质资源利用、优良基因发掘和育种效率,并为加快中药材新品种的定向培育提供了理论和方法.中药材种质资源收集鉴定是一项公益性的基础工作,本文系统论述中药材品种培育现状和面临的挑战,中药材种质创新的主要内容、基于基因组学的关键技术、种质创新基础平台建设策略等;基于中药种质资源杂合度高、与主要农作物育种具有差异性、中药材新品种选育目标应兼顾产量和质量等特点,展望了有序进行中药材育种核心种质及其品种定向培育研究的前景,提出具"内稳态"特征的中药材种质创新和新品种选育是现阶段主要任务之一,以期为中药材新品种选育提供理论和技术指导,进一步推动中药材种业的高质量发展.
Research strategy and prospects for the genomics-driven targeted breeding of Chinese herbal medicine varieties
In China,the area used to grow Chinese herbal medicinal plants continues to expand,reaching 90 million mu in 2021,with an output of 4.952 million tonnes.At present,the selection and breeding of these medicinal plants is mainly based on conventional breeding,resulting in relatively few elite varieties,with most little more than cultivated wild plants.Research into selection and breeding of high-quality,disease-resistant,stress-resistant,and storage-resistant varieties has been limited,making it difficult to meet the needs of large-scale,modernised agriculture and Chinese medicine.The germplasm purification,cross-breeding,and bio-breeding of Chinese herbal medicinal plants is very limited,and requires the improved selection and rational grouping of a core breeding germplasm.To promote and accelerate the cultivation of these medicinal plants,as well as to more broadly develop the seed industry,there is an urgent need to strengthen germplasm innovation in Chinese herbal medicinal plants,particularly for medicinal characteristics.Identifying and collecting germplasm resources is foundational work with societal benefits.The rational use of foreign varieties,local varieties,or wild relatives will play an important role in germplasm amplification,improvement,and innovation.The development of genomics technologies has promoted the use of Chinese herbal medicinal germplasm resources and the discovery of trait-associated genes,and has improved breeding efficiency by facilitating the targeted breeding of new varieties.This paper systematically discusses the current situation and challenges faced when cultivating Chinese herbal medicinal plants,their germplasm innovation,the key genomic technologies involved,and the strategies for constructing the basic platform to achieve these innovations.Chinese herbal medicinal plants have a high degree of heterozygosity,which poses breeding challenges that differ from those of major crops.The breeding objectives should consider both the yield and quality of the new varieties.Looking forward,we propose that germplasm innovation and the breeding of new varieties with"internal homeostasis"is one of the major tasks in the near future.The Chinese herbal medicinal germplasm resource management system includes four functional modules according to the breeding needs,providing germplasm resource and variety data retrieval query and comparison for open data,and convenient tools for the screening of breeding materials.This system supports the selection of materials involved in the breeding process,the management of information on field trials and the information on selection and breeding experiments.It also supports the management of the information on the material selection,field trial and selection trial,and new variety library management in the breeding process;establishing a resource collection task on the PC and collecting germplasm information through mobile phone programme.This system will become a bridge between germplasm resources and breeding research,and can be used for directional cultivation of parents and their varieties.With this review,we aim to provide theoretical and technological guidance for selecting and breeding Chinese herbal medicinal plants,which will promote further development of the high-quality medicinal plant seed industry.

medicinal plantstargeted breedinggermplasm enhancementgenomics

袁媛、黄璐琦

展开 >

中国中医科学院中药资源中心,道地药材品质保障与资源持续利用全国重点实验室,北京 100700

中药材 定向培育 种质创新 基因组学

国家杰出青年科学基金中国中医科学院科技创新工程中央本级重大增支减项目

82325049C12021B014/CI2021A0412060302

2024

科学通报
中国科学院国家自然科学基金委员会

科学通报

CSTPCD北大核心
影响因子:1.269
ISSN:0023-074X
年,卷(期):2024.69(4)
  • 70